BSE filing, NSE: CONCORDBIO. Summary written from the filing by ALFA Finder's alert engine.
Concord Biotech Ltd: key numbers
- Share price
- ₹1,268.50
- Market cap
- ₹13,271 Cr
- Revenue (annual)
- ₹1,055 Cr
- Net profit (annual)
- ₹260.9 Cr
- P/E (TTM)
- 47.0×Sector 46.1×
- Promoter holding
- 44.09%+0.01% QoQ
- FII holding
- 7.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Biotech Ltd
All →Concord Biotech Earnings Call Transcript: Key Takeaways
Revenue grew 25% YoY driven by API demand, but gross margins contracted 400bps due to rising solvent costs and geopolitical disruptions.
- Call
- Guides 18% growth
Concord Biotech Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹309.1 Cr (+25%) and PAT ₹69.6 Cr (+10%); H1 revenue ₹566.6 Cr (+26%). Margins compressed; Inspira dermatology division launched.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Concord Biotech Q2 FY27 Results: Net Profit ₹69.6 Cr, Up 10.3% YoY
Concord Biotech Ltd reported revenue from operations of ₹309.1 Cr (+25.1% YoY) and net profit of ₹69.6 Cr (+10.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹69.6 Cr · +10.3% YoY
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Concord Biotech Board Meeting Date
Concord Biotech has scheduled its Q2 FY27 board meeting for 27 Oct 2026 to approve standalone and consolidated results. Trading window remains closed until 48 hours post result declaration.
Other annual general meeting announcements
All →Tasty Bite Eatables Annual General Meeting
Tasty Bite Eatables declared postal ballot results approving a material related-party transaction with Mars Food UK Limited for purchase of a capital asset. Promoter group did not vote and the resolution passed with 99.99% of votes cast in favour.
Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Vedanta Iron and Steel Annual General Meeting
Vedanta Iron and Steel seeks shareholder approval via postal ballot for seven material related party transaction resolutions. E-voting runs from 29 October to 27 November 2026.
GTPL Hathway Annual General Meeting
GTPL Hathway seeks shareholder approval by postal ballot to appoint Gurjeev Singh Kapoor as Non-Executive Director. E-voting runs November 1 to 30, 2026.
HEG Advanced Materials Annual General Meeting
HEG Advanced Materials seeks approval via postal ballot to appoint seven directors and fix MD Riju Jhunjhunwala's remuneration. E-voting runs October 29 to November 27, 2026.
Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.